Therapeutic effects of melengestrol acetate, cyclophosphamide and palmitoyl cytarabine in established experimental allergic encephalomyelitis of rats.
D000311:Adrenal Glands; D000818:Animals; D001835:Body Weight; D001921:Brain / Q000473:pathology; D003520:Cyclophosphamide / Q000627:therapeutic use*; D003561:Cytarabine / Q000627:therapeutic use*; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000188:drug therapy* / Q000473:pathology; D004906:Erythrocyte Count; D005260:Female; D006400:Hematocrit; D006454:Hemoglobins; D007958:Leukocyte Count; D008099:Liver / Q000187:drug effects; D008552:Melengestrol Acetate / Q000627:therapeutic use; D009929:Organ Size; D010169:Palmitic Acids / Q000627:therapeutic use; D010243:Paralysis / Q000188:drug therapy; D011277:Pregnanediones; D011372:Progestins / Q000627:therapeutic use*; D051381:Rats; D013116:Spinal Cord / Q000473:pathology; D013154:Spleen; D013194:Staining and Labeling; D013950:Thymus Gland; D013997:Time Factors
D006454:Hemoglobins; D010169:Palmitic Acids; D011277:Pregnanediones; D011372:Progestins; D003561:Cytarabine; D008552:Melengestrol Acetate; D003520:Cyclophosphamide